Tumor-specific response of mixed lymphocyte tumor culture line to... | Download Scientific Diagram
A non-linear mixed effect model for innate immune response: In vivo kinetics of endotoxin and its induction of the cytokines tumor necrosis factor alpha and interleukin-6 | PLOS ONE
SSAT - OUTCOMES OF MIXED PATHOLOGIC RESPONSE IN PATIENTS WITH MULTIPLE COLORECTAL LIVER METASTASES TREATED WITH NEOADJUVANT CHEMOTHERAPY AND LIVER RESECTION
Elevated tumor markers for monitoring tumor response to immunotherapy - eClinicalMedicine
An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer | Nature Medicine
Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer | PLOS ONE
July 2021 – Hellen Phan-Lesti
Indicators of responsiveness to immune checkpoint inhibitors | Scientific Reports
Circulating tumor cell isolation for cancer diagnosis and prognosis - eBioMedicine
Glutathione-Triggered catalytic response of Copper-Iron mixed oxide Nanoparticles. Leveraging tumor microenvironment conditions for chemodynamic therapy - ScienceDirect
FDG-PET and contrast-enhanced CT. Radiological responses in patients... | Download Scientific Diagram
Metastatic breast carcinoma with mixed response to therapy
Frontiers | Dissociated Response in Metastatic Cancer: An Atypical Pattern Brought Into the Spotlight With Immunotherapy
PDF) Mixed response on regorafenib treatment for GIST (gastro-intestinal stromal tumor) according to 18F–FDG-PET/CT
CLO19-026: Determining the Treatment Decision of Tumors With Mixed Response in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 3.5 (2019)
JPM | Free Full-Text | Clinical Utility of Circulating Tumor Cells for Predicting Major Histopathological Response after Neoadjuvant Chemoradiotherapy in Patients with Esophageal Cancer
Frontiers | Complete Response to Immunotherapy Combined With Chemotherapy in a Patient With Gynecological Mixed Cancer Mainly Composed of Small Cell Neuroendocrine Carcinoma With High Tumor Mutational Burden: A Case Report
Multiplexed single-cell transcriptional response profiling to define cancer vulnerabilities and therapeutic mechanism of action | Nature Communications
Heterogeneity and Cancer
IJMS | Free Full-Text | Spatial and Temporal Changes in PD-L1 Expression in Cancer: The Role of Genetic Drivers, Tumor Microenvironment and Resistance to Therapy
Anakoinosis: Communicative Reprogramming of Tumor Systems - for Rescuing from Chemorefractory Neoplasia | SpringerLink
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging - ScienceDirect
Frontiers | Dissociated Response in Metastatic Cancer: An Atypical Pattern Brought Into the Spotlight With Immunotherapy
Spatial transcriptomics reveals key determinants of response to immune checkpoint blockade in NSCLC - by Explicyte Immuno-Oncology